Beam Therapeutics (BEAM) FCF Margin Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 43,511.00 |
| 10 | Beam Therapeutics | 3.40 Bn | 3.40 Bn | - | 99,821.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99,821.00 |
| Dec 31, 2025 | 16,552.00 |
| Sep 30, 2025 | -15,263.00 |
| Jun 30, 2025 | -25,256.00 |
| Mar 31, 2025 | -5,922.00 |
| Dec 31, 2024 | -27,846.00 |
| Sep 30, 2024 | -8,739.00 |
| Jun 30, 2024 | -22,835.00 |
| Mar 31, 2024 | -85,322.00 |
| Dec 31, 2023 | 60,297.00 |
| Sep 30, 2023 | -24,405.00 |
| Jun 30, 2023 | -3,426.00 |
| Mar 31, 2023 | -300,284.00 |
| Dec 31, 2022 | -61,231.00 |
| Sep 30, 2022 | 308,386.00 |
| Jun 30, 2022 | 42.42 Mn |
| Mar 31, 2022 | 83.68 Mn |
| Dec 31, 2021 | 44.27 Mn |
| Sep 30, 2021 | 38.45 Mn |
| Jun 30, 2021 | -4.88 Mn |
| Mar 31, 2021 | -36.05 Mn |
| Dec 31, 2020 | -27.75 Mn |
| Sep 30, 2020 | 5.32 Mn |
| Jun 30, 2020 | -19.81 Mn |